Melodiol Global Health (ASX:ME1DA) EV-to-Revenue : 0.64 (As of May. 12, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Melodiol Global Health EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Melodiol Global Health's enterprise value is A$12.03 Mil. Melodiol Global Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$18.92 Mil. Therefore, Melodiol Global Health's EV-to-Revenue for today is 0.64.

The historical rank and industry rank for Melodiol Global Health's EV-to-Revenue or its related term are showing as below:

ASX:ME1DA' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.57 Med: 17.03 Max: 4965.63
Current: 0.64

During the past 8 years, the highest EV-to-Revenue of Melodiol Global Health was 4965.63. The lowest was 0.57. And the median was 17.03.

ASX:ME1DA's EV-to-Revenue is ranked better than
88.7% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 2.41 vs ASX:ME1DA: 0.64

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-12), Melodiol Global Health's stock price is A$0.013. Melodiol Global Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.13. Therefore, Melodiol Global Health's PS Ratio for today is 0.10.

Melodiol Global Health EV-to-Revenue Historical Data

The historical data trend for Melodiol Global Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health EV-to-Revenue Chart

Melodiol Global Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

6.02

65.21

15.02

4.83

0.97

Melodiol Global Health Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial										15.02	-	4.83	-	0.97

Competitive Comparison of Melodiol Global Health's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Melodiol Global Health's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's EV-to-Revenue falls into.

Melodiol Global Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Melodiol Global Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	12.028	/	18.921
	=	0.64

Melodiol Global Health's current Enterprise Value is A$12.03 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Melodiol Global Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$18.92 Mil.

Melodiol Global Health (ASX:ME1DA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Melodiol Global Health's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.013	/	0.134
	=	0.10

Melodiol Global Health's share price for today is A$0.013.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was A$0.13.

Melodiol Global Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Melodiol Global Health (ASX:ME1DA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (ASX:ME1DA) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

COPHF:USA

Address

145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009

Website

https://www.cresopharma.com

Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (ASX:ME1DA) Headlines

No Headlines